- Home
- MMU vs PRME Comparison
MMU vs PRME Comparison
Compare MMU & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MMU | PRME |
|---|---|---|
| Founded | 1992 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 567.5M | 666.1M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | MMU | PRME |
|---|---|---|
| Price | $10.49 | $4.04 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $6.42 |
| AVG Volume (30 Days) | 170.7K | ★ 3.7M |
| Earning Date | 01-01-0001 | 02-27-2026 |
| Dividend Yield | ★ 4.92% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $5,977,000.00 |
| Revenue This Year | N/A | $111.80 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 647.13 |
| 52 Week Low | $8.60 | $1.11 |
| 52 Week High | $10.45 | $6.94 |
Technical Indicators
Market Signals| Indicator | MMU | PRME |
|---|---|---|
| Relative Strength Index (RSI) | 56.66 | 58.09 |
| Support Level | $10.37 | $3.29 |
| Resistance Level | $10.48 | $4.12 |
| Average True Range (ATR) | 0.10 | 0.25 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 79.76 | 86.93 |
Price Performance
Historical ComparisonAbout MMU Western Asset Managed Municipals Fund Inc.
Western Asset Managed Municipals Fd Inc is a non-diversified, closed-end management investment company. Its investment objective is to maximize current income exempted from federal income tax as is consistent with the preservation of principal. The fund predominantly invests in long-term investment grade municipal debt securities issued by state and local governments, political subdivisions, agencies, and public authorities (municipal obligations).
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.